Northwestern Mutual Wealth Management Co. Increases Holdings in Agilent Technologies, Inc. $A

Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 452.7% during the fourth quarter, Holdings Channel reports. The firm owned 21,981 shares of the medical research company’s stock after acquiring an additional 18,004 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Agilent Technologies were worth $2,991,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Flynn Zito Capital Management LLC boosted its position in Agilent Technologies by 3.2% during the 3rd quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock valued at $290,000 after acquiring an additional 69 shares in the last quarter. Gabelli Funds LLC boosted its position in Agilent Technologies by 1.1% during the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after acquiring an additional 74 shares in the last quarter. Fiduciary Trust Co boosted its position in Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after acquiring an additional 77 shares in the last quarter. NorthCrest Asset Manangement LLC boosted its position in Agilent Technologies by 1.6% during the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after acquiring an additional 79 shares in the last quarter. Finally, Freestone Capital Holdings LLC boosted its position in Agilent Technologies by 2.0% during the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after acquiring an additional 84 shares in the last quarter.

Analyst Upgrades and Downgrades

Several research firms have weighed in on A. Barclays cut their price objective on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Morgan Stanley cut their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. UBS Group cut their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. TD Cowen cut their price objective on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Wells Fargo & Company cut their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $163.71.

Agilent Technologies Stock Performance

Shares of A opened at $115.01 on Tuesday. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The business’s 50 day moving average price is $114.84 and its 200-day moving average price is $129.23. Agilent Technologies, Inc. has a 52 week low of $107.07 and a 52 week high of $160.27. The stock has a market cap of $32.50 billion, a P/E ratio of 25.39, a P/E/G ratio of 2.42 and a beta of 1.22.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period in the prior year, the firm earned $1.31 earnings per share. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is presently 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.